Jab only part effective on Omicron: Study

By Michael Erman
Updated December 8 2021 - 2:01pm, first published 1:56pm
Vaccine makers are scrambling to tackle uncertainty over the Omicron variant.
Vaccine makers are scrambling to tackle uncertainty over the Omicron variant.

The Omicron variant can partially evade the protection from two doses of Pfizer's COVID-19 vaccine, the research head of a laboratory in South Africa says.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Singleton news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.